Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations.
Rajwa P, Quhal F, Pradere B, Gandaglia G, Ploussard G, Leapman MS, Gore JL, Paradysz A, Tilki D, Merseburger AS, Morgan TM, Briganti A, Palapattu GS, Shariat SF. Rajwa P, et al. Among authors: briganti a. Nat Rev Urol. 2023 Apr;20(4):205-216. doi: 10.1038/s41585-022-00680-4. Epub 2023 Jan 4. Nat Rev Urol. 2023. PMID: 36600087 Review.
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation.
Chun FK, Briganti A, Shariat SF, Graefen M, Montorsi F, Erbersdobler A, Steuber T, Salonia A, Currlin E, Scattoni V, Friedrich MG, Schlomm T, Haese A, Michl U, Colombo R, Heinzer H, Valiquette L, Rigatti P, Roehrborn CG, Huland H, Karakiewicz PI. Chun FK, et al. Among authors: briganti a. BJU Int. 2006 Aug;98(2):329-34. doi: 10.1111/j.1464-410X.2006.06262.x. BJU Int. 2006. PMID: 16879673
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
Gallina A, Chun FK, Briganti A, Shariat SF, Montorsi F, Salonia A, Erbersdobler A, Rigatti P, Valiquette L, Huland H, Graefen M, Karakiewicz PI. Gallina A, et al. Among authors: briganti a. Eur Urol. 2007 Jul;52(1):98-105. doi: 10.1016/j.eururo.2007.01.060. Epub 2007 Jan 22. Eur Urol. 2007. PMID: 17267098 Clinical Trial.
Systematic assessment of the ability of the number and percentage of positive biopsy cores to predict pathologic stage and biochemical recurrence after radical prostatectomy.
Briganti A, Chun FK, Hutterer GC, Gallina A, Shariat SF, Salonia A, Scattoni V, Valiquette L, Montorsi F, Rigatti P, Graefen M, Huland H, Karakiewicz PI. Briganti A, et al. Eur Urol. 2007 Sep;52(3):733-43. doi: 10.1016/j.eururo.2007.02.054. Epub 2007 Mar 6. Eur Urol. 2007. PMID: 17350750
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millennium.
Chun FK, Briganti A, Gallina A, Hutterer GC, Shariat SF, Antebie E, Walz J, Roehrborn CG, Salonia A, Rigatti P, Saad F, Huland H, Montorsi F, Graefen M, Karakiewicz PI. Chun FK, et al. Among authors: briganti a. Eur Urol. 2007 Oct;52(4):1067-74. doi: 10.1016/j.eururo.2007.03.018. Epub 2007 Mar 20. Eur Urol. 2007. PMID: 17383807
1,471 results